Takeda Pharmaceutical (TAK) Total Liabilities: 2018-2025

Historic Total Liabilities for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $48.0 billion.

  • Takeda Pharmaceutical's Total Liabilities fell 9.34% to $47.9 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $47.9 billion, marking a year-over-year decrease of 9.34%. This contributed to the annual value of $48.0 billion for FY2025, which is 11.64% down from last year.
  • According to the latest figures from FY2025, Takeda Pharmaceutical's Total Liabilities is $48.0 billion, which was down 11.64% from $54.3 billion recorded in FY2024.
  • Over the past 5 years, Takeda Pharmaceutical's Total Liabilities peaked at $73.0 billion during FY2021, and registered a low of $48.0 billion during FY2025.
  • Over the past 3 years, Takeda Pharmaceutical's median Total Liabilities value was $54.3 billion (recorded in 2024), while the average stood at $52.9 billion.
  • Data for Takeda Pharmaceutical's Total Liabilities shows a maximum YoY decreased of 15.69% (in 2023) over the last 5 years.
  • Over the past 5 years, Takeda Pharmaceutical's Total Liabilities (Yearly) stood at $73.0 billion in 2021, then declined by 8.51% to $66.8 billion in 2022, then decreased by 15.69% to $56.3 billion in 2023, then fell by 3.47% to $54.3 billion in 2024, then fell by 11.64% to $48.0 billion in 2025.